Ceftazidime-avibactam plus metronidazole vs. meropenem in complicated intra-abdominal infections: Indian subset from RECLAIM

Ceftazidime-avibactam plus metronidazole vs. meropenem in complicated intra-abdominal infections: Indian subset from RECLAIM

Introduction: This study analyzes the safety and efficacy results of the Indian population subset from the RECLAIM trial investigating the non-inferiority of Ceftazidime-Avibactam (CAZ-AVI) plus metronidazole to meropenem and interprets its relevance. Methodology: The study design, subjects incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Prithi Rodgers, Shweta Kamat, Charles Adhav
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2022-02-01
Series:Journal of Infection in Developing Countries
Subjects:
Ceftazidime
avibactam
meropenem
intra-abdominal infections
RECLAIM
Online Access:https://jidc.org/index.php/journal/article/view/14912
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/14912

Similar Items